Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Redeye: Redeye Initiates Coverage of Kontigo Care

Kontigo Care
Download the release

Redeye initiates coverage on Kontigo Care with a base case of SEK 12 per share. Kontigo offers an innovative AI-driven solution for treating alcohol and gambling addiction (drug addiction treatment in the pipeline). The addressable market is large and underserved and Kontigo’s treatment platform is uniquely sophisticated. Revenues come from long-term contracts and licenses with a long duration, and the business is easily scalable. Our valuation shows that Kontigo currently trades significantly below fair value. We argue that the company is a clever investment case, especially in times of market turbulence, and looming recession.

Read more and download the Research Report.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Redeye Initiates Coverage of Kontigo Care

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.